Lancet Capital, the first SBIC affiliated with an academic medical center, was founded in 1998 by William Golden and George Sing to create value for investors and founders/management of early stage biomedical portfolio companies.
Lancet invests in exceptional researchers, clinicians and entrepreneurs to commercialize innovative technologies in the biomedical field. Lancet is able to offer value-adding human capital in the venture-building process by providing:
- Startup senior management
- Startup operations expertise
- Business planning
- Recruitment of management
- Access to key resources and expertise